Cytonus Therapeutics Becomes Axiom Biosciences, Pairing Its Regenerative Medicine Programs With AI-Enabled Drug Design
New name reflects the company’s growth from a regenerative medicine innovator into a broader therapeutics company, with its clinical-stage cell therapy programs remaining at the core SAN DIEGO, June 23,